Project

Strengthening the UGent patent position on an improved cultivation method for adoptive cell therapies (immuno-oncology).

Acronym
CAR-NK
Code
F2019/IOF-ConcepTT/048
Duration
01 April 2019 → 31 March 2020
Funding
Regional and community funding: Industrial Research Fund
Research disciplines
  • Medical and health sciences
    • Immunology not elsewhere classified
Keywords
T cells dendritic cells immunotherapy Transcription factors hematopoietic stem cells differentiation
 
Project description

The researchers have developed an improved culture method for natural killer (NK) immune cells for use in adoptive cell therapy, and further research will be carried out to strengthen the Ghent University patent position.